4-[4-(3,4-Dichlorophenyl)-1,3-thiazol-2-yl]-N-methylbenzamide

Catalog No.: 
ACGRPA533
CAS No.: 
338408-28-9
Molecular Formula: 
C17H12Cl2N2OS
Molecular Weight: 
363.27
4-[4-(3,4-Dichlorophenyl)-1,3-thiazol-2-yl]-N-methylbenzamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$108.00InquiryInquiry
1g90%$323.00InquiryInquiry
5g90%$1599.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[4-(3,4-Dichlorophenyl)-1,3-thiazol-2-yl]-N-methylbenzamide
IUPAC Name4-(4-(3,4-dichlorophenyl)thiazol-2-yl)-N-methylbenzamide
Molecular FormulaC17H12Cl2N2OS
Molecular Weight363.27
SMILESO=C(NC)C1=CC=C(C2=NC(C3=CC=C(Cl)C(Cl)=C3)=CS2)C=C1
InChI KeyRSUMKWOPGXQGBJ-UHFFFAOYSA-N
Synonym4-[4-(3,4-DICHLOROPHENYL)-1,3-THIAZOL-2-YL]-N-METHYLBENZENECARBOXAMIDE;4-[4-(3,4-dichlorophenyl)-1,3-thiazol-2-yl]-N-methylbenzamide;Benzamide, 4-[4-(3,4-dichlorophenyl)-2-thiazolyl]-N-methyl-
CAS No.338408-28-9

Synthetic Route by SureRoute

1. ACGRPA533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAPRM547 route compound structure diagram
    ACAPRM5472632-10-2In Stock
  4. Then
  5. ACGRPA533 route product structure diagram
    ACGRPA533338408-28-9
Inquiry

2. ACGRPA533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGRPA533 route product structure diagram
    ACGRPA533338408-28-9
Inquiry

3. ACGRPA533 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACGRPA533 route product structure diagram
    ACGRPA533338408-28-9
Inquiry

Comments (0)